Citation Impact
Citing Papers
Acquired Immunity to Malaria
2009
Nucleic acid detection with CRISPR-Cas13a/C2c2
2017 StandoutScience
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Plasmacytoid dendritic cells appear inactive during sub-microscopic Plasmodium falciparum blood-stage infection, yet retain their ability to respond to TLR stimulation
2017
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
Immunogenicity of Whole-Parasite Vaccines against Plasmodium falciparum Involves Malarial Hemozoin and Host TLR9
2010
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
2010 Standout
Common West African HLA antigens are associated with protection from severe malaria
1991 StandoutNature
T and B cell Tolerance and Responses to Viral Antigens in Transgenic Mice: Implications for the Pathogenesis of Autoimmune versus Immunopathological Disease
1991
T-Cell Antigens and Epitopes in Malaria Vaccine Design
1990
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
2002 StandoutNature
Effector and memory T-cell differentiation: implications for vaccine development
2002 Standout
Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
2011 Standout
Lack of H‐2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide
1991
Pattern Recognition Receptors and Inflammation
2010 Standout
Mechanism of splenic cell death and host mortality in a Plasmodium yoelii malaria model
2017
A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children
2002
The Transcriptome of the Intraerythrocytic Developmental Cycle of Plasmodium falciparum
2003 Standout
Tolerance, Danger, and the Extended Family
1994 Standout
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Potent Induction of Focused Th1‐Type Cellular and Humoral Immune Responses by RTS,S/SBAS2, a RecombinantPlasmodium falciparumMalaria Vaccine
1999
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Myasthenia Gravis
1994 Standout
Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection
2011
Clinical Presentation and Bacteriologic Analysis of Infected Human Bites in Patients Presenting to Emergency Departments
2003
PD-1 Co-inhibitory and OX40 Co-stimulatory Crosstalk Regulates Helper T Cell Differentiation and Anti-Plasmodium Humoral Immunity
2015
Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii
1990
Exploring in vitro expression and immune potency in mice using mRNA encoding the Plasmodium falciparum malaria antigen, CelTOS
2022 StandoutNobel
Malaria
2013 Standout
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Swab Sample Transfer for Point-Of-Care Diagnostics: Characterization of Swab Types and Manual Agitation Methods
2014
Broad-Spectrum Antibiotic or G-CSF as Potential Countermeasures for Impaired Control of Bacterial Infection Associated with an SPE Exposure during Spaceflight
2015 StandoutNobel
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
1991 StandoutNature
The economic and social burden of malaria
2002 StandoutNature
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Genomic and Functional Characterization of Enterococcus faecalis Isolates Recovered From the International Space Station and Their Potential for Pathogenicity
2021 StandoutNobel
Pre-erythrocytic malaria vaccines: towards greater efficacy
2005
Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.
1994 StandoutNobel
Molecular Methods and Platforms for Infectious Diseases Testing
2011
Strategies for designing and optimizing new generation vaccines
2001
T‐Helper Epitopes on Human Nicotinic Acetylcholine Receptor in Myasthenia Gravisa
1993
A Malaria Vaccine Candidate Based on a Hepatitis B Virus Core Platform
2002
The Effects of Probiotics in Early Enteral Nutrition on the Outcomes of Trauma
2012
Hindlimb Suspension and SPE-Like Radiation Impairs Clearance of Bacterial Infections
2014 StandoutNobel
Predicting HLA CD4 Immunogenicity in Human Populations
2018
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
2020 Standout
The immune recognition of malaria antigens
1991
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
2016 Standout
Control of the Immune Response at the Level of Antigen-Presenting Cells: A Comparison of the Function of Dendritic Cells and B Lymphocytes
1989 StandoutNobel
Treatment of Tularemia with Fluoroquinolones: Two Cases and Review
1999
Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates
2010 StandoutNobel
Stimulation of Human Anti-Viral CD8+ Cytolytic T Lymphocytes by Dendritic Cells
1995 StandoutNobel
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
2007 Standout
Molecular analysis of the association of HLA-B53 and resistance to severe malaria
1992 Nature
Tularemia as a Biological Weapon
2001 Standout
Antimicrobial reactive oxygen and nitrogen species: concepts and controversies
2004 Standout
Interleukin 10–Mediated Immunosuppression by a Variant CD4 T Cell Epitope of Plasmodium falciparum
1999
Ciprofloxacin for treatment of tularemia in children
2000
Towards a blood-stage vaccine for malaria: are we following all the leads?
2001
Peptide-primed CD4+ cells and malaria sporozoites
1990
Molecular and cellular insights into T cell exhaustion
2015 Standout
Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii
2010 StandoutNobel
Regulation of Immunity to Parasites by T Cells and T Cell-Derived Cytokines
1992 Standout
Protection against a Malaria Challenge by Sporozoite Inoculation
2009
Toll-Like Receptor Signaling Pathways
2014 Standout
Interferon-γ: The Jekyll and Hyde of Malaria
2015
Rationale for the Development of an Engineered Sporozoite Malaria Vaccine
1989
Malaria vaccines: immunogen selection and epitope mapping
1988
Association of Early Interferon‐γ Production with Immunity to Clinical Malaria: A Longitudinal Study among Papua New Guinean Children
2008
Structural basis of antigen recognition by T lymphocytes. Implications for vaccines.
1988
Phase 1 Evaluation of 3 Highly Immunogenic Prime‐Boost Regimens, Including a 12‐Month Reboosting Vaccination, for Malaria Vaccination in Gambian Men
2004
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Infection Prevention and Control During Prolonged Human Space Travel
2012
Enzyme Immunoassay (EIA)/Enzyme-Linked Immunosorbent Assay (ELISA)
2005 Standout
Conserved Repetitive Epitope Recognized by CD4 + Clones From a Malaria-Immunized Volunteer
1989 Science
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes.
1990
RTP4 inhibits IFN-I response and enhances experimental cerebral malaria and neuropathology
2020 StandoutNobel
Mapping T-cell epitopes in group A streptococcal type 5 M protein
1991
Pathogenesis of Group A Streptococcal Infections
2000 Standout
Preclinical Safety and Efficacy Assessments of Dendrimer-Based (SPL7013) Microbicide Gel Formulations in a Nonhuman Primate Model
2006
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
[40] Identification of T-cell epitopes and use in construction of synthetic vaccines
1989
Immunization of woodchucks with adjuvanted sHDAg (p24): immune response and outcome following challenge
2003 StandoutNobel
T Cell Studies in a Peptide-Induced Model of Systemic Lupus Erythematosus
2001 StandoutNobel
Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research
2005
Approaches to Malaria Vaccine Development Using the Retrospectroscope
2009
Yellow fever 17D as a vaccine vector for microbial CTL epitopes
2005 StandoutNobel
An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.
1988
APlasmodium-encoded cytokine suppresses T-cell immunity during malaria
2012
Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+T cells
2000 StandoutNobel
B cell–intrinsic TBK1 is essential for germinal center formation during infection and vaccination in mice
2021 StandoutNobel
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Sporozoite Vaccine Induces Genetically Restricted T Cell Elimination of Malaria from Hepatocytes
1989 Science
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
2006 StandoutNobel
Pre-Erythrocytic Vaccines against Malaria
2020
Works of D Pombo being referenced
A Six-Year Descriptive Study of Hospital-Associated Infection in Trauma Patients: Demographics, Injury Features, and Infection Patterns
2007
Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers
2000
Relapse of Tularemia After Aminoglycoside Therapy: Case Report and Discussion of Therapeutic Options
1995
Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum
2002
Human and murine CD4 T cell epitopes map to the same region of the malaria circumsporozoite protein: limited immunogenicity of sporozoites and circumsporozoite protein.
1988
Neonatal exposure to immunogenic peptides. Differential susceptibility to tolerance induction of helper T cells and B cells reactive to malarial circumsporozoite peptide epitopes.
1988
Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule.
1988
Parasite polymorphism present within minimal T cell epitopes of Plasmodium falciparum circumsporozoite protein.
1988
Differential non-Responsiveness in Humans of Candidate Plasmodium Falciparum Vaccine Antigens
1989
Multicenter Evaluation of the LightCycler Methicillin-Resistant Staphylococcus aureus (MRSA) Advanced Test as a Rapid Method for Detection of MRSA in Nasal Surveillance Swabs
2010
Recombinant human IL-2 overcomes genetic nonresponsiveness to malaria sporozoite peptides. Correlation of effect with biologic activity of IL-2.
1988